|
gptkbp:instanceOf
|
gptkb:public_company
|
|
gptkbp:CEO
|
gptkb:Brett_P._Monia
|
|
gptkbp:country
|
gptkb:United_States
|
|
gptkbp:CUSIP
|
462222100
|
|
gptkbp:focus
|
RNA-targeted therapeutics
|
|
gptkbp:formerName
|
gptkb:Isis_Pharmaceuticals,_Inc.
|
|
gptkbp:foundedYear
|
1989
|
|
gptkbp:founder
|
gptkb:Stanley_T._Crooke
|
|
gptkbp:hasCompany
|
gptkb:Ionis_Pharmaceuticals,_Inc.
|
|
gptkbp:headquartersLocation
|
gptkb:Carlsbad,_California,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
NASDAQ: IONS
|
|
gptkbp:industry
|
gptkb:biotechnology
|
|
gptkbp:ISIN
|
US4622221004
|
|
gptkbp:marketCap
|
large-cap
|
|
gptkbp:notableProduct
|
gptkb:Spinraza
gptkb:Tegsedi
gptkb:Waylivra
|
|
gptkbp:numberOfEmployees
|
~800
|
|
gptkbp:stockExchange
|
gptkb:NASDAQ
|
|
gptkbp:stockSymbol
|
gptkb:IONS
|
|
gptkbp:website
|
https://www.ionispharma.com/
|
|
gptkbp:bfsParent
|
gptkb:Ionis_Pharmaceuticals
|
|
gptkbp:bfsLayer
|
6
|